Table 8.
Effect of methanolic extract of Myrica nagi (MEMN) on kidney and liver weight in a high-fat diet (HFD) model.
| a | ||||||
|---|---|---|---|---|---|---|
| Organ | Control (I) | Inducer (II) | Standard (III) | MEMN (100 mg/kg) (IV) | MEMN (200 mg/kg) (V) | MEMN (400 mg/kg) (VI) |
| Liver(gm) | 0.916 ± 0.113 | 1.56 ± 0.119### | 1.01 ± 0.101∗∗∗ | 1.42 ± 0.11ns | 1.36 ± 0.05∗∗ | 1.26 ± 0.112∗∗∗ |
| b | ||
|---|---|---|
| Groups | Treatment | Liver (gm) |
| I | Normal Control | 0.82 ± 0.10 |
| II | Gold thioglucose (300 mg/kg, i.p.) | 1.76 ± 0.22### |
| III | GTG + Orlistat (100 mg/kg, p.o.) | 1.12 ± 0.08∗∗∗ |
| IV | GTG + MEMN (100 mg/kg, p.o.) | 1.48 ± 0.09∗∗∗ |
| V | GTG + MEMN (200 mg/kg, p.o.) | 1.38 ± 0.14∗∗∗ |
| VI | GTG + MEMN (400 mg/kg, p.o.) | 1.15 ± 0.05∗∗∗ |
Methanolic extract of M. nagi., MEMN; p.o., per oral. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ###p < 0.001, #p < 0.05, ##p < 0.01, #When compared with normal control group, ∗when compared with inducer group.